Clinical trial to evaluate safety and efficacy of radiofrequency ablation for malignant tumors located outside the liver
- Conditions
- malignant tumors which have lesions located outside the liver
- Registration Number
- JPRN-UMIN000012109
- Lead Sponsor
- Division of Diagnostic Imaging and Minimally Invasive Therapy, Juntendo University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 20
Not provided
1)Tumors not visualized by ultrasonography/not accessible percutaneously 2)Patients in whom ablation of the tumors is highly likely to cause damage of other organs or tissues 3)Patients with marked bleeding tendency 4)Patients with The American Society of Anesthesiologists physical state (ASA PS) 3 or more 5)Patients who cannot follow instructions because of dementia 6)Patients in whom therapeutic efficacy cannot be evaluated with contrast-enhanced CT scan or others, because of renal dysfunction or adverse reactions to contrast agents 7)Patients in whom effective measures, such as transfusion and others, cannot be used for adverse events because of religious reasons or others 8)Patients considered to be ineligible for participation in the study by the investigator or subinvestigators
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Overall survival Frequency of adverse events
- Secondary Outcome Measures
Name Time Method ocal tumor progression rate Recurrence rate